73 results
8-K
EX-1.1
CGTX
Cognition Therapeutics Inc
13 Mar 24
Entry into a Material Definitive Agreement
4:07pm
. The Company owns or has a valid right to access and use all computer systems, networks, hardware, software, databases, websites and equipment used … where the failure to own or have the right to access the Company IT Systems would not reasonably be expected to have a Material Adverse Effect
424B5
CGTX
Cognition Therapeutics Inc
13 Mar 24
Prospectus supplement for primary offering
4:04pm
Westchester Ave., Purchase, New York 10577, Attn: Chief Executive Officer.
You also may access these filings on our website at www.cogrx.com. We do … that we specifically incorporate by reference into this prospectus supplement or the accompanying prospectus). You may also access these filings
424B5
nz5651
11 Mar 24
Prospectus supplement for primary offering
4:06pm
8-K
EX-10.1
h2j4gbc7uk
20 Feb 24
Departure of Directors or Certain Officers
4:44pm
424B4
b10rs8v
8 Jan 24
Prospectus supplement with pricing info
4:11pm
8-K
EX-99.1
j6ezx
8 Aug 23
Cognition Therapeutics Reports Second Quarter 2023 Financial Results and Business Update
7:05am
8-K
EX-99.1
wso4f5i ob
4 May 23
Cognition Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Update
4:06pm
8-K
EX-10.1
17q5prm2 ewdrcoogkr
1 May 23
Departure of Directors or Certain Officers
7:30am
8-K
EX-10.1
784jqsr2e
23 Dec 22
Entry into a Material Definitive Agreement
4:24pm
S-3
m4o2i7luhmlw f2fgyyz
23 Dec 22
Shelf registration
4:16pm
S-3
EX-1.2
b790ortppvy hhcgo15
23 Dec 22
Shelf registration
4:16pm